{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:55:40Z","timestamp":1792691740897,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T00:00:00Z","timestamp":1387238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11906-013-0408-6","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T01:16:44Z","timestamp":1387156604000},"source":"Crossref","is-referenced-by-count":46,"title":["Membrane Estrogen Receptors: Their Role in Blood Pressure Regulation and Cardiovascular Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Roopashree","family":"Prabhushankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"issue":"1","key":"408_CR1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ. Heart disease and stroke statistics\u20132012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2\u2013220. doi: 10.1161\/CIR.0b013e31823ac046 .","journal-title":"Circulation"},{"issue":"8","key":"408_CR2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933\u201344. doi: 10.1161\/CIR.0b013e31820a55f5 .","journal-title":"Circulation"},{"issue":"4","key":"408_CR3","first-page":"103","volume":"60","author":"Y Ostchega","year":"2011","unstructured":"Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control \u2013 continued disparities in adults: United States, 2005\u20132006. NCHS Data Brief No. 3. Hyattsville, MD: National Center for Health Statistics. 2008. MMWR. 2011;60(4):103\u20138.","journal-title":"MMWR"},{"issue":"1","key":"408_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/oby.20181","volume":"21","author":"L Landsberg","year":"2013","unstructured":"Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment\u2013a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring). 2013;21(1):8\u201324. doi: 10.1002\/oby.20181 .","journal-title":"Obesity (Silver Spring)"},{"key":"408_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","volume":"14","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013;14:5\u201312. doi: 10.1007\/s11154-012-9229-1 .","journal-title":"Rev Endocr Metab Disord"},{"key":"408_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2042-6410-3-7","volume":"3","author":"K Sandberg","year":"2012","unstructured":"Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:7. doi: 10.1186\/2042-6410-3-7 . Comprehensive review of the biological differences in blood pressure both in animal models and in humans.","journal-title":"Biol Sex Differ"},{"key":"408_CR7","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.1977.03270490025018","volume":"237","author":"Blood pressure studies in 14 communities","year":"1977","unstructured":"Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA. 1977;237:2385\u201391.","journal-title":"JAMA"},{"key":"408_CR8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","volume":"109","author":"E Murphy","year":"2011","unstructured":"Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109:687\u201396. doi: 10.1161\/CIRCRESAHA.110.236687 . Author reviews the available evidence of estrogen action in the vasculature.","journal-title":"Circ Res"},{"key":"408_CR9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.steroids.2012.04.001","volume":"77","author":"M Barton","year":"2012","unstructured":"Barton M. Position paper: The membrane estrogen receptor GPER\u2013Clues and questions. Steroids. 2012;77:935\u201342. doi: 10.1016\/j.steroids.2012.04.001 .","journal-title":"Steroids"},{"key":"408_CR10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.3753802","volume":"231","author":"GL Greene","year":"1986","unstructured":"Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986;231:1150\u20134.","journal-title":"Science"},{"key":"408_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0039-128X(69)90004-X","volume":"13","author":"SG Korenman","year":"1969","unstructured":"Korenman SG. Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids. 1969;13:163\u201377.","journal-title":"Steroids"},{"key":"408_CR12","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","volume":"93","author":"GG Kuiper","year":"1996","unstructured":"Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"408_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/0929867003375010","volume":"7","author":"K Dechering","year":"2000","unstructured":"Dechering K, Boersma C, Mosselman S. Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem. 2000;7:561\u201376.","journal-title":"Curr Med Chem"},{"key":"408_CR14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","volume":"138","author":"GG Kuiper","year":"1997","unstructured":"Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863\u201370.","journal-title":"Endocrinology"},{"key":"408_CR15","doi-asserted-by":"crossref","first-page":"36869","DOI":"10.1074\/jbc.R100029200","volume":"276","author":"JM Hall","year":"2001","unstructured":"Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001;276:36869\u201372.","journal-title":"J Biol Chem"},{"key":"408_CR16","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.ATV.19.8.1925","volume":"19","author":"C Giannattasio","year":"1999","unstructured":"Giannattasio C, Failla M, Grappiolo A, Stella ML, Del Bo A, Colombo M, et al. Fluctuations of radial artery distensibility throughout the menstrual cycle. Arterioscler Thromb Vasc Biol. 1999;19:1925\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"408_CR17","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1074\/jbc.R110.191791","volume":"286","author":"Q Wu","year":"2011","unstructured":"Wu Q, Chambliss K, Umetani M, Mineo C, Shaul PW. Non-nuclear estrogen receptor signaling in the endothelium. J Biol Chem. 2011;286:14737\u201343. doi: 10.1074\/jbc.R110.191791 .","journal-title":"J Biol Chem"},{"key":"408_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/265069a0","volume":"265","author":"RJ Pietras","year":"1977","unstructured":"Pietras RJ, Szego CM. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977;265:69\u201372.","journal-title":"Nature"},{"key":"408_CR19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","volume":"14","author":"EJ Filardo","year":"2000","unstructured":"Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14:1649\u201360.","journal-title":"Mol Endocrinol"},{"key":"408_CR20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","volume":"146","author":"P Thomas","year":"2005","unstructured":"Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624\u201332.","journal-title":"Endocrinology"},{"key":"408_CR21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","volume":"307","author":"CM Revankar","year":"2005","unstructured":"Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625\u201330.","journal-title":"Science"},{"key":"408_CR22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/HYPERTENSIONAHA.107.089995","volume":"49","author":"E Haas","year":"2007","unstructured":"Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension. 2007;49:1358\u201363.","journal-title":"Hypertension"},{"key":"408_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","volume":"2","author":"CG Bologa","year":"2006","unstructured":"Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2:207\u201312.","journal-title":"Nat Chem Biol"},{"key":"408_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000315497","volume":"86","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Baretella O, Prossnitz ER, Barton M. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology. 2010;86:58\u201364. doi: 10.1159\/000315497 .","journal-title":"Pharmacology"},{"key":"408_CR25","doi-asserted-by":"crossref","first-page":"H1055","DOI":"10.1152\/ajpheart.00878.2009","volume":"298","author":"BR Broughton","year":"2010","unstructured":"Broughton BR, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol. 2010;298:H1055\u201361. doi: 10.1152\/ajpheart.00878.2009 .","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","volume":"104","author":"E Haas","year":"2009","unstructured":"Haas E, Bhattacharya I, Brailoiu E, Damjanovi\u0107 M, et al. Regulatory role of G protein\u2013coupled estrogen receptor for vascular function and obesity. Circ Res. 2009;104:288\u201391. doi: 10.1161\/CIRCRESAHA.108.190892 . Authors explore role of GPER-1 in isolated VSMC. First description of the GPER-1 knockout rodent.","journal-title":"Circ Res"},{"key":"408_CR27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/en.2008-0623","volume":"150","author":"UE M\u00e5rtensson","year":"2009","unstructured":"M\u00e5rtensson UE, Salehi SA, Windahl S, Gomez MF, et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology. 2009;150:687\u201398. doi: 10.1210\/en.2008-0623 .","journal-title":"Endocrinology"},{"key":"408_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.111.184606","volume":"59","author":"MR Meyer","year":"2012","unstructured":"Meyer MR, Amann K, Field AS, et al. Deletion of G protein\u2013coupled estrogen receptor increases endothelial vasoconstriction. Hypertension. 2012;59:507\u201312. doi: 10.1161\/HYPERTENSIONAHA.111.184606 .","journal-title":"Hypertension"},{"key":"408_CR29","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1152\/ajpendo.00649.2012","volume":"305","author":"SH Lindsey","year":"2013","unstructured":"Lindsey SH, da Silva AS, Silva MS, Chappell MC. Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am J Physiol Endocrinol Metab. 2013;305:E113\u20138. doi: 10.1152\/ajpendo.00649.2012 . Authors explore the effect of G1 agonists in male and female rats, as well as estradiol signaling via GPER-1.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"408_CR30","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1210\/en.2008-1664","volume":"150","author":"SH Lindsey","year":"2009","unstructured":"Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology. 2009;150:3753\u20138.","journal-title":"Endocrinology"},{"key":"408_CR31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/FJC.0b013e3182135f1c","volume":"57","author":"SH Lindsey","year":"2011","unstructured":"Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol. 2011;57:598\u2013603.","journal-title":"J Cardiovasc Pharmacol"},{"key":"408_CR32","doi-asserted-by":"crossref","first-page":"C1178","DOI":"10.1152\/ajpcell.00185.2009","volume":"297","author":"Q Ding","year":"2009","unstructured":"Ding Q, Gros R, Limbird LE, Chorazyczewski J, Feldman RD. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am J Physiol Cell Physiol. 2009;297:C1178\u201387. doi: 10.1152\/ajpcell.00185.2009 .","journal-title":"Am J Physiol Cell Physiol"},{"key":"408_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","volume":"62","author":"SB Bender","year":"2013","unstructured":"Bender SB, McGraw AP, Jaffe IZ, Sowers JR. Mineralocorticoid receptor\u2013mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes. 2013;62:313\u20139. doi: 10.2337\/db12-0905 .","journal-title":"Diabetes"},{"key":"408_CR34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","volume":"57","author":"R Gros","year":"2011","unstructured":"Gros R, Ding Q, Sklar LA, et al. GPR30 expression is required for the mineralocorticoid receptor\u2013independent rapid vascular effects of aldosterone. Hypertension. 2011;57:442\u201351. doi: 10.1161\/HYPERTENSIONAHA.110.161653 . Interesting article demonstrating signaling of aldosterone via GPER-1.","journal-title":"Hypertension"},{"key":"408_CR35","doi-asserted-by":"crossref","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","volume":"304","author":"R Gros","year":"2013","unstructured":"Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol. 2013;304:C532\u201340. doi: 10.1152\/ajpcell.00203.2012 .","journal-title":"Am J Physiol Cell Physiol"},{"key":"408_CR36","doi-asserted-by":"crossref","first-page":"H1806","DOI":"10.1152\/ajpheart.00283.2009","volume":"297","author":"AM Deschamps","year":"2009","unstructured":"Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol. 2009;297:H1806\u201313. doi: 10.1152\/ajpheart.00283.2009 .","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR37","doi-asserted-by":"crossref","first-page":"e15433","DOI":"10.1371\/journal.pone.0015433","volume":"5","author":"JA Jessup","year":"2010","unstructured":"Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L. Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS ONE. 2010;5:e15433.","journal-title":"PLoS ONE"},{"key":"408_CR38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/en.2012-1558","volume":"154","author":"P Garrido","year":"2013","unstructured":"Garrido P, Moran J, Alonso A, Gonzalez S, Gonzalez C. 17\u03b2-estradiol activates glucose uptake via GLUT4 translocation and PI3K\/Akt signaling pathway in MCF-7 cells. Endocrinology. 2013;154:1979\u201389. doi: 10.1210\/en.2012-1558 .","journal-title":"Endocrinology"},{"key":"408_CR39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI5347E1","volume":"103","author":"Z Chen","year":"1999","unstructured":"Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al. Estrogen receptor \u03b1 mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:1363. doi: 10.1172\/JCI5347E1 .","journal-title":"J Clin Invest"},{"issue":"7","key":"408_CR40","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI38291","volume":"120","author":"KL Chambliss","year":"2010","unstructured":"Chambliss KL, Wu Q, Oltmann S, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010;120(7):2319\u201330. doi: 10.1172\/JCI38291 . Authors elegantly explore the beneficial vascular effects of membrane estrogen receptor alpha agonism with a new compound without proliferative effects in mammary gland or uterus.","journal-title":"J Clin Invest"},{"key":"408_CR41","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/me.2005-0525","volume":"20","author":"A Pedram","year":"2006","unstructured":"Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol. 2006;20:1996\u20132009.","journal-title":"Mol Endocrinol"},{"key":"408_CR42","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","volume":"293","author":"SA Cooper","year":"2007","unstructured":"Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293:H2009\u201323.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR43","doi-asserted-by":"crossref","first-page":"H1770","DOI":"10.1152\/ajpheart.01011.2005","volume":"292","author":"B Xue","year":"2007","unstructured":"Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol. 2007;292:H1770\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR44","doi-asserted-by":"crossref","first-page":"H1577","DOI":"10.1152\/ajpheart.01255.2008","volume":"296","author":"B Xue","year":"2009","unstructured":"Xue B, Badaue-Passos Jr D, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone\/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol. 2009;296:H1577\u201385. doi: 10.1152\/ajpheart.01255.2008 .","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"408_CR45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1065250","volume":"295","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Bian Z, Lu P, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 2002;295:505\u20138.","journal-title":"Science"},{"key":"408_CR46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/HYPERTENSIONAHA.111.00903","volume":"61","author":"B Xue","year":"2013","unstructured":"Xue B, Zhang Z, Beltz TG, et al. Estrogen receptor-\u03b2 in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone\/salt-induced hypertension in female rats. Hypertension. 2013;61:1255\u201362. doi: 10.1161\/HYPERTENSIONAHA.111.00903 .","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-013-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-013-0408-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-013-0408-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T19:27:45Z","timestamp":1564946865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-013-0408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s11906-013-0408-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,17]]},"article-number":"408"}}